Jerini Hosts Conference Call on Phase III Clinical Trials of Icatibant for Hereditary Angioedema


BERLIN, Sept. 21, 2006 (PRIMEZONE) -- Jerini AG (FSE:JI4) will host an audio webcast and conference call, including an open question and answer session, on Friday, September 22nd, 2006, to discuss the results of its two Phase III trials.

Date: September 22, 2006

Time: 11:00 a.m. CET / 05:00 a.m. EST

Telephone Access:



 +49 (0)69 5007 1307  Deutschland
 +44 (0)20 7806 1955  UK
 +1 718 354 1388      USA
 +41 (0)43 456 9299   Schweiz

Please dial-in 10 minutes prior to start of the conference call.

To View the Presentation Online:

To view the presentation with audio, go to the Jerini website (www.jerini.com) and follow the instructions for accessing the live audio webcast.

The replay of the webcast will be available online (www.jerini.com), 2 hours after the end of the conference call, through December 22, 2006.

ISIN: DE0006787476



            

Contact Data